| The pivotal link between ACE2 deficiency and SARS-CoV-2 infection P Verdecchia, C Cavallini, A Spanevello, F Angeli European journal of internal medicine 76, 14-20, 2020 | 1348 | 2020 |
| Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma E CRIMI, A Spanevello, M NERI, PW IND, GA ROSSI, V BRUSASCO American journal of respiratory and critical care medicine 157 (1), 4-9, 1998 | 686 | 1998 |
| An electronic nose in the discrimination of patients with asthma and controls S Dragonieri, R Schot, BJA Mertens, S Le Cessie, SA Gauw, ... Journal of allergy and clinical immunology 120 (4), 856-862, 2007 | 544 | 2007 |
| A European Respiratory Society technical standard: exhaled biomarkers in lung disease I Horváth, PJ Barnes, S Loukides, PJ Sterk, M Högman, AC Olin, A Amann, ... European Respiratory Journal 49 (4), 2017 | 522 | 2017 |
| An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD S Dragonieri, JT Annema, R Schot, MPC van der Schee, A Spanevello, ... Lung cancer 64 (2), 166-170, 2009 | 496 | 2009 |
| Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis G Sotgiu, R Centis, L D'Ambrosio, JWC Alffenaar, HA Anger, JA Caminero, ... European Respiratory Journal 40 (6), 1430-1442, 2012 | 493 | 2012 |
| Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases M Tadolini, LR Codecasa, JM García-García, FX Blanc, S Borisov, ... European Respiratory Journal 56 (1), 2020 | 489 | 2020 |
| Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR-and XDR-TB: a multicentre study SE Borisov, K Dheda, M Enwerem, RR Leyet, L D'Ambrosio, R Centis, ... European Respiratory Journal 49 (5), 2017 | 367 | 2017 |
| Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis GB Migliori, G Sotgiu, NR Gandhi, D Falzon, K DeRiemer, R Centis, ... European Respiratory Journal 42 (1), 169-179, 2013 | 323 | 2013 |
| Tele-assistance in chronic respiratory failure patients: a randomised clinical trial M Vitacca, L Bianchi, A Guerra, C Fracchia, A Spanevello, B Balbi, ... European Respiratory Journal 33 (2), 411-418, 2009 | 316 | 2009 |
| Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study DS Postma, C Brightling, S Baldi, M Van den Berge, LM Fabbri, ... The Lancet Respiratory Medicine 7 (5), 402-416, 2019 | 293 | 2019 |
| Induced sputum cellularity: reference values and distribution in normal volunteers A Spanevello, M Confalonieri, F Sulotto, F Romano, G Balzano, ... American journal of respiratory and critical care medicine 162 (3), 1172-1174, 2000 | 293 | 2000 |
| European union standards for tuberculosis care GB Migliori, JP Zellweger, I Abubakar, E Ibraim, JA Caminero, G De Vries, ... European Respiratory Journal 39 (4), 807-819, 2012 | 289 | 2012 |
| Clinical and operational value of the extensively drug-resistant tuberculosis definition GB Migliori, G Besozzi, E Girardi, K Kliiman, C Lange, OS Toungoussova, ... European Respiratory Journal 30 (4), 623-626, 2007 | 278 | 2007 |
| Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts I Motta, R Centis, L D’Ambrosio, JM García-García, D Goletti, G Gualano, ... Pulmonology 26 (4), 233-240, 2020 | 253 | 2020 |
| Epidemiology and clinical management of XDR-TB: a systematic review by TBNET G Sotgiu, G Ferrara, A Matteelli, MD Richardson, R Centis, ... European Respiratory Journal 33 (4), 871-881, 2009 | 241 | 2009 |
| Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease M Confalonieri, E Mainardi, R Della Porta, S Bernorio, L Gandola, ... Thorax 53 (7), 583-585, 1998 | 238 | 1998 |
| Worldwide effects of coronavirus disease pandemic on tuberculosis services, January–April 2020 GB Migliori, PM Thong, O Akkerman, JW Alffenaar, F Álvarez-Navascués, ... Emerging infectious diseases 26 (11), 2709, 2020 | 225 | 2020 |
| MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network GB Migliori, S Tiberi, A Zumla, E Petersen, JM Chakaya, C Wejse, ... International Journal of Infectious Diseases 92, S15-S25, 2020 | 218 | 2020 |
| Efficacy and safety of meropenem–clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB S De Lorenzo, JW Alffenaar, G Sotgiu, R Centis, L D'Ambrosio, S Tiberi, ... European Respiratory Journal 41 (6), 1386-1392, 2013 | 208 | 2013 |
